| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_ZEB1_0002200 | Intron-Exon-Intron | chr10:31625728-31647262 | chr10:31336799-31358333 | 318 nt | 0.4277 |
| hsa_ZEB1_0002300 | Intron-Exon-Intron | chr10:31625728-31663893 | chr10:31336799-31374964 | 162 nt | 0.3580 |
| hsa_ZEB1_0002400 | Intron-Exon-Intron | chr10:31625728-31676195 | chr10:31336799-31387266 | 226 nt | 0.4292 |
| hsa_ZEB1_0002500 | Intron-Exon-Intron | chr10:31625728-31676727 | chr10:31336799-31387798 | 79 nt | 0.3671 |
| hsa_ZEB1_0002600 | Intron-Exon-Intron | chr10:31625728-31713578 | chr10:31336799-31424649 | 225 nt | 0.3600 |
| hsa_ZEB1_0002100 | Intron-Exon-Intron | chr10:31625728-31750166 | chr10:31336799-31461237 | 250 nt | 0.3640 |
| hsa_chr10_0275100 | Intergenic-Intergenic | chr10:31626761-31627062 | chr10:31337832-31338133 | 302 nt | 0.4139 |
| hsa_chr10_0275200 | Intergenic-Intergenic | chr10:31626765-31627062 | chr10:31337836-31338133 | 298 nt | 0.4094 |
| hsa_chr10_0275300 | Intergenic-Intergenic | chr10:31626857-31627062 | chr10:31337928-31338133 | 206 nt | 0.3738 |
| hsa_ZEB1_0002700 | Intron-Intron | chr10:31627321-31628336 | chr10:31338392-31339407 | 1016 nt | 0.3494 |
A study in humans identified the circZEB1 as a potential biomarker for immune-mediated demyelinating disease, where its levels in cerebrospinal fluid exosomes were specifically validated [Misir et al. DOI:10.1038/s41418-022-00948-7]. A study in humans demonstrated that circZEB1 was upregulated in left atrial appendages of patients with atrial fibrillation [Tian et al. DOI:10.3390/molecules26041155].